As we here in the UK brace for a second national lockdown, I’m pleased to be able to share some good news in the hunt for effective COVID-19 treatments. Fujifilm Toyama Chemical’s anti-influenza drug Avigan has met its primary endpoint in a phase III trial for COVID-19 and is looking to file for approval in Japan. Elsewhere, we Sit Down With Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia, and David Jones of Rapid Micro Biosystems makes the case for modernizing QC in biopharma.

All the best and stay safe! James Strachan, Deputy Editor
 
CLINICAL TRIALS
Pandemic Protection
10/29/2020 | Stephanie Vine
Fujifilm Toyama's influenza treatment passes COVID-19 trial.
BUSINESS PRACTICE
Adapting to Change
10/30/2020 | Maryam Mahdi
Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.
QUALITY & COMPLIANCE
A Brave New World of Quality
10/26/2020 | David Jones
QC must evolve to meet progress in biopharmaceutical manufacturing.
BUSINESS PRACTICE
Stemming the Brain Drain
10/22/2020 | Kelly Chibale
What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?
 
Webinars
Interested in AAV-based gene therapies?

Don’t miss our three-part educational webinar series with Cytiva that covers modern plasmid and AAV production for gene therapy applications. Find out more
Expand Your Operations Without Astronomical Costs!

Multimodal suites can help you shift your operations as technologies change, business expands, and patient needs evolve. Don’t miss our upcoming webinar with CRB’s SlateXpace on November 11, 2020. Find out more
 
White Papers
Exploring the relationship between molecular characteristics and bulk rheological properties of biodegradable polymers

Molecular and bulk characterization of PLA and PLGA samples using multi-detector GPC and rheometry. Read More.
Understanding Excipient Functionality in a Formulation

The aim of formulation development is to design a product and its manufacturing process to consistently deliver the intended Quality Target Product Profile (QTPP).  Read More.
 
Product Profiles
Qualicaps®, contributing to bridge the gap between medicine and treatment

Qualicaps® created the first gelatin capsule for inhalation via DPI devices, and subsequently the first hypromellose capsule, Quali-V®-I, specially formulated to achieve exceptional performance. Read more
iLAB: Intelligent Lean Lab (a product + process solution)

iLAB uses decision sciences and business analytics. The product is a virtual replica of a physical lab’s infrastructure and operation. It prescribes a lab design using business management principles. Read more
Accelerate your high throughput enzyme screening with Cataplatta™

Discover how JM’s offering can quickly expand your enzyme screening portfolio. The Cataplatta™ enzymes have been selected for their activity on an extensive selection of substrates, meeting the different synthetic needs of customers. Read more
 
Special Promotions
Nominate today for The Medicine Maker 2021 Power List!

Who in the drug development and manufacturing industry do you feel deserves a spot in this prestigious list? Nominate today in our three categories celebrating influential medicine makers! Find out more
The Cell + Gene Curator - a newsletter focused on the science of cell and gene therapies

Connecting you to discoveries, innovation, and business updates from the cell and gene therapy community. Learn more and subscribe
 
Must-See Events Worldwide

We work with event organizers from all around the world to help bring the pharma industry together, from large congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and and stay up-to-date with the latest developments.
Find out more
This email was sent to {~email~} by info@themedicinemaker.com. To ensure delivery of emails to your inbox, please add info@themedicinemaker.com to your address book or safe sender list. To view online, please click here.

Create or manage your account here
Unsubscribe here

The Medicine Maker is a brand of Texere Publishing Limited (trading as Conexiant)

Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.